Sale of 20,989 Colgate-Palmolive (CL) shares planned after option exercise

Rhea-AI Filing Summary

Colgate-Palmolive common stock holder plans to sell shares under Rule 144. A holder has filed a notice to sell 20,989 shares of Colgate-Palmolive common stock through Merrill Lynch on or about 02/10/2026, with an indicated aggregate market value of $1,978,210.97 on the NYSE.

The shares were acquired on 02/10/2026 from Colgate-Palmolive via an employee stock option exercise structured as a broker-assisted cashless exercise. Colgate-Palmolive had 806,064,942 shares outstanding at the time referenced, providing context for the relative size of this planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	20989	1978210.97	806064942	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/2026	Exercise of employee stock options	COLGATE PALMOLIVE CO			20989	02/10/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for Colgate-Palmolive (CL) disclose?

The filing discloses an intention to sell 20,989 shares of Colgate-Palmolive common stock. The planned sale is through Merrill Lynch on or about February 10, 2026, with an indicated aggregate market value of $1,978,210.97 on the New York Stock Exchange.

How many Colgate-Palmolive (CL) shares are planned to be sold and on what exchange?

The notice states that 20,989 shares of Colgate-Palmolive common stock are planned for sale. The shares are to be sold on the New York Stock Exchange, with Merrill Lynch listed as the broker handling the transaction for the selling holder.

How were the Colgate-Palmolive (CL) shares in this Form 144 acquired?

The shares were acquired on February 10, 2026, through the exercise of employee stock options from Colgate-Palmolive. The transaction was structured as a broker-assisted cashless exercise, meaning the broker facilitated exercising options and selling shares to cover costs.

What is the aggregate market value of the Colgate-Palmolive (CL) shares to be sold?

The filing lists an aggregate market value of $1,978,210.97 for the 20,989 Colgate-Palmolive common shares to be sold. This value reflects the indicated market price reference used in the notice for the planned New York Stock Exchange sale.

How many Colgate-Palmolive (CL) shares were outstanding when this Form 144 was prepared?

The document reports 806,064,942 Colgate-Palmolive common shares outstanding. This figure provides context for the size of the planned 20,989-share sale relative to the company’s total common stock at the referenced time.